Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm, Residual × Clonal Evolution × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1 Neoplasm, Residual 1

Interventions

Blood Specimen Collection 6 Liquid Biopsy 3 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 pegaspargase 1 Vincristine 1 Trastuzumab 1 Transplantation, Autologous 1 Prednisone 1 Methotrexate 1 Mercaptopurine 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Clonal Evolution 1 Anti-Inflammatory Agents, Non-Steroidal 1 Aminolevulinic Acid 1 Ado-Trastuzumab Emtansine 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03521596 2025-11-18

FIL_BIOWM

Fondazione Italiana Linfomi - ETS

Waldenstrom Macroglobulinemia, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡